| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.1998.8891 |
| P698 | PubMed publication ID | 9647779 |
| P2093 | author name string | Gullans SR | |
| Dangond F | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 833-837 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate | |
| P478 | volume | 247 |
| Q39677863 | Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation |
| Q73085665 | Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation |
| Q39887718 | Autoregulation of mouse histone deacetylase 1 expression |
| Q43025836 | Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients |
| Q40152021 | COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. |
| Q37464695 | Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia |
| Q33912107 | Cloning and characterization of human histone deacetylase 8. |
| Q36972324 | Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock |
| Q45300254 | Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. |
| Q39011776 | Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. |
| Q34093068 | Differentiation therapy of human cancer: basic science and clinical applications |
| Q47880039 | Epigenetic modifications in brain and immune cells of multiple sclerosis patients |
| Q34312272 | Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease |
| Q37130888 | Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis |
| Q53393798 | Expression profile of histone deacetylase 1 in gastric cancer tissues. |
| Q43987548 | Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells |
| Q35016981 | HDAC inhibition in lupus models |
| Q34193936 | Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code |
| Q40310696 | Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation |
| Q44022398 | Histone deacetylase inhibition results in decreased macrophage CD9 expression |
| Q36353207 | Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity |
| Q34393807 | Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? |
| Q34119504 | Histone deacetylase inhibitors: novel anticancer agents |
| Q35092304 | Histone deacetylase regulation of immune gene expression in tumor cells |
| Q24535587 | Histone deacetylases (HDACs): characterization of the classical HDAC family |
| Q37621256 | Histone deacetylases and the immunological network: implications in cancer and inflammation |
| Q33941116 | Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes |
| Q34050126 | Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs |
| Q39689901 | Identification and analysis of the promoter region of the human DHCR24 gene: involvement of DNA methylation and histone acetylation |
| Q38753861 | Improving understanding of chromatin regulatory proteins and potential implications for drug discovery |
| Q28377610 | Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53 |
| Q34338533 | Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo |
| Q34635234 | Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock |
| Q55258538 | Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways. |
| Q40227388 | Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate |
| Q33616120 | Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly |
| Q35809469 | Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors |
| Q44548998 | Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
| Q44210670 | Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis |
| Q35855571 | Regulation of immune responses by histone deacetylase inhibitors |
| Q36980243 | Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors |
| Q44321035 | Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors |
| Q44047926 | Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). |
| Q34015778 | The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines |
| Q43842959 | The effect of the histone deacetylase inhibitor, trichostatin A, on total histone synthesis, H1(0) synthesis and histone H4 acetylation in peripheral blood lymphocytes increases as a function of increasing age: a model study |
| Q43878365 | The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells |
| Q38314584 | Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS). |
| Q34480485 | Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells |
Search more.